FDA OKs Sapien 3 for Mitral, Aortic Valve-in-Valve Replacement

Limited to high-surgical-risk patients, the expanded indication marks the first approval of any transcatheter valve for treatment of failed mitral and aortic bioprostheses, says the agency.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s